Spansules Pharmatech

Hyderabad, India
A WHO GMP and ISO 9001:2008 certified manufacturer and exporter of pharmaceutical pellets.

About Spansules Pharmatech

Spansules Pharmatech is a Healthcare company based in Hyderabad (India). It operates as an a WHO GMP and ISO 9001:2008 certified manufacturer and exporter of pharmaceutical pellets. It operates on a B2B model. The company has 52 employees. Its Indian entity Spansules Pharmatech Private Limited reported revenue of β‚Ή73.76 Cr. Its focus areas include Pharmaceuticals, Manufacturing and Pellet Production. Its competitors include Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma and 5 more; 4 of its 10 listed competitors have raised funding.

Company details

Spansules Pharmatech a who gmp and iso 9001:2008 certified manufacturer and exporter of pharmaceutical pellets, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and pellet production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Key Metrics
  • Annual Revenue
    ₹73.76 Cr

    FY 2025 · -4% YoY

  • Net Profit
    ₹1.73 Cr

    FY 2025 · 2% margin

  • EBITDA
    ₹8.06 Cr

    FY 2025 · 11% margin

  • Employee Count
    52

Board of directors of Spansules Pharmatech Private Limited (Spansules Pharmatech)

Spansules Pharmatech Private Limited is the primary company behind Spansules Pharmatech. The board of Spansules Pharmatech Private Limited currently have 4 directors; the longest-serving is Rama Devi Guttikonda, appointed in 2000.

DirectorDesignationAppointedTenureEntity
Rama Devi Guttikonda
DIN 02019526
Director09 Oct 200026 yrsSpansules Pharmatech Private Limited
Venkata Subba Rao Guttikonda
DIN 01900749
Managing Director09 Oct 200026 yrsSpansules Pharmatech Private Limited
Haswanth Rao Guttikonda
DIN 06368794
Director07 Feb 20206 yrs 8 moSpansules Pharmatech Private Limited
Harika Rao Guttikonda
DIN 07585257
Director07 Feb 20206 yrs 8 moSpansules Pharmatech Private Limited

Financials of Spansules Pharmatech

Figures of Spansules Pharmatech Private Limited, the primary company behind Spansules Pharmatech, for FY 2025. Revenue was ₹73.76 Cr (-4% year on year). Net profit was ₹1.73 Cr (2% margin). EBITDA was ₹8.06 Cr (11% margin). Revenue has grown at a compounded annual rate of -2% over three years and +5% over five years.

  • ₹73.76 CrRevenue · FY 2025 · -4% YoY
  • ₹1.73 CrNet profit · 2% margin
  • ₹8.06 CrEBITDA · 11% margin
  • ₹5.00 CrPaid-up capital
  • 52Employees (provident fund records)
  • -2%Revenue CAGR, 3 years
  • +5%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Spansules Pharmatech Private Limited are on its company page.

Premium access

Detailed financial statements for Spansules Pharmatech

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Spansules Pharmatech

Spansules Pharmatech has 10 listed competitors in our database, 4 of them funded. They include Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
almacgroup.com2001Craigavon, United Kingdom$338.8M2,109
Integrated CDMO services for biopharma R&D and manufacturing are offered.
indoco.com1947Mumbai, India–6,291
APIs manufacturing and formulation services are provided in therapeutic segments.
concordbiotech.com2000Ahmedabad, India–1,598
APIs and enzymes are manufactured through fermentation by the CDMO.
bdrpharma.com2003Mumbai, India$88.16M1,864
APIs and finished products are developed and manufactured.
aurobindo.com1986Hyderabad, India–1,010
Generic biocatalytic solutions are provided for pharmaceutical applications.
asymchem.com1995Morrisville, United States–48
APIs and peptides are developed and manufactured by Asymchem.
seqens.com2003Ecully, France–44
Contract manufacturing services for small molecules and peptides are provided.
continuuspharma.com2012Woburn, United States$7.73M47
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development
pharm-int.com1994Hunt Valley, United States–248
Pharmaceutical dosage forms are manufactured by this CDMO.
aptuit.com2004Greenwich, United States$14.23M–
Contract research and development services for small molecules are offered.
Premium access

Detailed competitors of Spansules Pharmatech

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Spansules Pharmatech

The website of Spansules Pharmatech (spansulespharma.net) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▲ 69.7% vs previous month

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Spansules Pharmatech (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 213.52 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Spansules Pharmatech

Spansules Pharmatech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Spansules Pharmatech has 52 employees.

The primary company behind Spansules Pharmatech, Spansules Pharmatech Private Limited, reported revenue of β‚Ή73.76 Cr for FY 2025, down 4% year on year.

Spansules Pharmatech a who gmp and iso 9001:2008 certified manufacturer and exporter of pharmaceutical pellets, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and pellet production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Spansules Pharmatech's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.

Spansules Pharmatech operates through Spansules Pharmatech Private Limited.

The legal entities of Spansules Pharmatech currently have 4 directors, including Rama Devi Guttikonda, Haswanth Rao Guttikonda, Harika Rao Guttikonda and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available